Tag: CLF UWS USA NAM CHN ASA NYK UNE

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

CHENGDU, China, June 6, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsCLF UWS USA NAM CHN ASA NYK UNE

FSK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that FS KKR Capital Corp. Investors with Substantial Losses Have Opportunity to Lead Investor...

SpaceX IPO Project Unlimited (Weiss Ratings’ Michael Robinson Disruptors & Dominators Newsletter) Elon’s Trillion Dollar Plan to Save AI

Prime Drink Group Announces Private Placement and Agreed Resolution with Creditors

Tag: CLF UWS USA NAM CHN ASA NYK UNE

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us